Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer

Emelie Rådestad, Charlotte Klynning, Arwen Stikvoort, +4

OncoImmunology

Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes

Melissa M. Norström, Emelie Rådestad, Berit Sundberg, +4

Oncotarget

InflammationCytokineUrologyAutoimmune DiseaseChronic Activation +12

Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors

Emelie Rådestad, H. Wikell, Mathias Engström, +6

Journal of Immunology Research

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease

Arwen Stikvoort, Yang Chen, Emelie Rådestad, +12

Frontiers in Immunology

Cgvhd SeverityCell TherapyImmunologyPathologyImmunophenotyping +17

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels

Deepika Nair, Emelie Rådestad, Prajakta Khalkar, +6

Frontiers in Oncology

Chemoprevention StrategySe CompoundsImmunologyImmunoeditingCell Death +19

CD8⁺<i>γδ</i> T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

Ahmed Gaballa, Lucas C. M. Arruda, Emelie Rådestad, +1

Stem Cells International

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion

Emelie Rådestad, Mikael Sundin, Johan Törlén, +6

Frontiers in Immunology

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue

Emelie Rådestad, Lars Egevad, Carl Jorns, +7

Oncotarget

Novel method to characterize immune cells from human prostate tissue

Melissa M. Norström, Emelie Rådestad, Arwen Stikvoort, +6

The Prostate

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang, +1756

Journal for ImmunoTherapy of Cancer